Lexington Biosciences Concludes Initial HeartSentry Clinical Study
27 juin 2018 08h30 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...